Fasoracetam hmoov chaw tsim tshuaj paus CAS No.: 110958-19-5 99% purity min. rau cov khoom xyaw ntxiv
Product Video
Khoom Parameters
Khoom npe | Fasoracetam |
Lwm lub npe | FASORACETAM; (5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone; (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-ib; (5R)-5-piperidin-1-ylcarbonylpyrrolidin-2-ib |
CAS Nr. | 110958-19-5 |
Cov mis mos molecular | C10H16N2O2 |
Molecular hnyav | 196.25 Nws |
Purity | 99.0% |
Qhov tshwm sim | Dawb crystalline hmoov |
Ntim | 1 kg / hnab 25kg / nruas |
Daim ntawv thov | Nootropic |
Khoom taw qhia
Fasoracetam, yog ib qho nootropic compound thawj zaug hauv Nyiv. Nws qhia cov qauv zoo sib xws nrog lwm cov neeg sib tw xws li piracetam, tab sis nthuav tawm cov yam ntxwv tshwj xeeb. Fasoracetam xav los hloov cov teebmeem ntawm ntau yam neurotransmitters hauv lub hlwb, suav nrog GABA, glutamatergic, thiab cholinergic systems. Los ntawm kev cuam tshuam rau kev tso tawm thiab kev txhawb nqa ntawm cov neurotransmitters, fasoracetam tuaj yeem txhim kho kev txawj ntse xws li kev saib xyuas, kev sib koom ua ke ntawm kev nco, thiab kev ua cov ntaub ntawv. Kev tshawb fawb thiab cov ntaub ntawv pov thawj qhia tau hais tias fasoracetam tuaj yeem muab ntau yam txiaj ntsig zoo. Ib qho ntawm nws cov txiaj ntsig tseem ceeb yog txhawm rau txhim kho kev mloog zoo thiab kev saib xyuas, ua rau nws muaj peev xwm pab tau rau cov neeg muaj kev cuam tshuam los ntawm kev tsis txaus siab tsis txaus siab lossis tsis txaus siab tsis txaus ntseeg (ADD / ADHD). Cov kev tshawb fawb ua ntej tau pom cov txiaj ntsig tau zoo, ua kom pom fasoracetam lub peev xwm los txhim kho kev mloog, txo qis kev xav thiab txhim kho kev txawj ntse. Tsis tas li ntawd, cov kev tshawb fawb tsiaj pom tias Fasoracetam txhim kho lub sijhawm ntev, cov txheej txheem cuam tshuam nrog kev tsim kev nco thiab synaptic plasticity.
Feature
(1) High purity: Fasoracetam tuaj yeem tau txais cov khoom lag luam siab huv los ntawm kev ua kom zoo dua qub. High purity txhais tau hais tias bioavailability zoo dua thiab tsawg dua qhov tsis zoo.
(2) Kev Nyab Xeeb: Cov kev tshawb fawb tau pom tias fasoracetam feem ntau tau txais txiaj ntsig zoo thiab tsis pom cov kev mob tshwm sim tseem ceeb thaum siv hauv cov koob tshuaj pom zoo.
(3) Kev ruaj ntseg: Fasoracetam muaj kev ruaj ntseg zoo thiab tuaj yeem tswj hwm nws cov haujlwm thiab cov txiaj ntsig hauv qhov chaw sib txawv thiab kev cia khoom.
Daim ntawv thov
Fasoracetam tau tshwm sim los ua ib qho chaw zoo nkauj nrog lub peev xwm los txhim kho kev txawj ntse, tshwj xeeb yog kev nco, kev mloog, thiab kev kawm, thiab tuaj yeem siv los ua kev noj haus ntxiv. Cov khoom no ua raws li lub cim xeeb txhim kho los ntawm kev txhawb cov metabolic glutamate receptors. Hauv kev ua liaj ua teb lom neeg, Fasoracetam kuj tseem siv los ua ib qho kev xaiv inhibitor los kawm txog cov txheej txheem lom neeg xws li xov tooj ntawm tes thiab apoptosis.